Hiranmayi Ravichandran

Hiranmayi Ravichandran

Auto-generated profile, based on publicly available information

Hiranmayi Ravichandran

Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2017 in Science
Verified
Journal Article
Open access
PDF file
AVAndrew S. Venteicher
Andrew S. Venteicher
ITItay Tirosh
Itay Tirosh
CHChristine Hebert
Christine Hebert
KYKeren Yizhak
Keren Yizhak
CNCyril Neftel
Cyril Neftel
MSMario L. Suvà
Mario L. Suvà
Single-cell RNA sequencing identifies a common origin for specific types of human glioma brain tumors.

1 March 2020 in Cell Reports
Verified
Journal Article
Open access
AMAndrea J. De Micheli
Andrea J. De Micheli
ELEmily J. Laurilliard
Emily J. Laurilliard
CHCharles L. Heinke
Charles L. Heinke
HRHiranmayi Ravichandran
Hiranmayi Ravichandran
PFPaula Fraczek
Paula Fraczek
BCBenjamin D. Cosgrove
Benjamin D. Cosgrove
Muscle regeneration relies on the regulation of muscle stem cells (MuSCs) through paracrine signaling interactions. We analyzed muscle regeneration in mice using single-cell RNA sequencing (scRNA-seq) and generated over 34,000 single-cell transcriptomes spanning four time-points. We identified 15 distinct cell types including heterogenous populations of muscle stem and progenitor cells. We resolved a hierarchical map of these myogenic cells by trajectory inference and observed stage-specific regulatory programs within this continuum. Through ligand-receptor interaction analysis, we identified over 100 candidate regeneration-associated paracrine communication pairs between MuSCs and non-myogenic cells. We show that myogenic stem/progenitor cells exhibit heterogeneous expression of multiple Syndecan proteins in cycling myogenic cells, suggesting that Syndecans may coordinate myogenic fate regulation. We performed ligand stimulation in vitro and confirmed that three paracrine factors (FGF2, TGFβ1, and RSPO3) regulate myogenic cell proliferation in a Syndecan-dependent manner. Our study provides a scRNA-seq reference resource to investigate cell communication interactions in muscle regeneration.

31 January 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
MKMihriban Karaayvaz-Yildirim
Mihriban Karaayvaz-Yildirim
RSRebecca E. Silberman
Rebecca E. Silberman
ALAdam Langenbucher
Adam Langenbucher
SSSrinivas Vinod Saladi
Srinivas Vinod Saladi
KRKenneth N. Ross
Kenneth N. Ross
LELeif W. Ellisen
Leif W. Ellisen
Normal breast epithelia from BRCA2 mutation carriers display DNA damage and attenuated checkpoint responses.

18 March 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
KOKentaro Ohara
Kentaro Ohara
ARAndré Figueiredo Rendeiro
André Figueiredo Rendeiro
BBBhavneet Bhinder
Bhavneet Bhinder
KEKenneth Wha Eng
Kenneth Wha Eng
HRHiranmayi Ravichandran
Hiranmayi Ravichandran
JMJuan Miguel Mosquera
Juan Miguel Mosquera
The molecular characteristics of metastatic upper tract urothelial carcinoma (UTUC) are not well understood, and there is a lack of knowledge regarding the genomic and transcriptomic differences between primary and metastatic UTUC. To address these gaps, we integrate whole-exome sequencing, RNA sequencing, and Imaging Mass Cytometry using lanthanide metal-conjugated antibodies of 44 tumor samples from 28 patients with high-grade primary and metastatic UTUC. We perform a spatially-resolved single-cell analysis of cancer, immune, and stromal cells to understand the evolution of primary to metastatic UTUC. We discover that actionable genomic alterations are frequently discordant between primary and metastatic UTUC tumors in the same patient. In contrast, molecular subtype membership and immune depletion signature are stable across primary and matched metastatic UTUC. Molecular and immune subtypes are consistent between bulk RNA-sequencing and mass cytometry of protein markers from 340,798 single cells. Molecular subtypes at the single-cell level are highly conserved between primary and metastatic UTUC tumors within the same patient.

29 November 2022 in medRxiv
Verified
Preprint
Open access
PDF file
ARAndré F. Rendeiro
André F. Rendeiro
HRHiranmayi Ravichandran
Hiranmayi Ravichandran
JKJunbum Kim
Junbum Kim
ABAlain Borczuk
Alain Borczuk
OEOlivier Elemento
Olivier Elemento
RSRobert E. Schwartz
Robert E. Schwartz
SARS-CoV-2 infection can manifest as a wide range of respiratory and systemic symptoms well after the acute phase of infection in over 50% of patients. Key questions remain on the long-term effects of infection on tissue pathology in recovered COVID-19 patients. To address these questions we performed multiplexed imaging of post-mortem lung tissue from 12 individuals who died post-acute COVID-19 (PC) and compare them to lung tissue from patients who died during the acute phase of COVID-19, or patients who died with idiopathic pulmonary fibrosis (IPF), and otherwise healthy lung tissue. We find evidence of viral presence in the lung up to 359 days after the acute phase of disease, including in patients with negative nasopharyngeal swab tests. The lung of PC patients are characterized by the accumulation of senescent alveolar type 2 cells, fibrosis with hypervascularization of peribronchial areas and alveolar septa, as the most pronounced pathophysiological features. At the cellular level, lung disease of PC patients, while distinct, shares pathological features with the chronic pulmonary disease of IPF. which may help rationalize interventions for PC patients. Altogether, this study provides an important foundation for the understanding of the long-term effects of SARS-CoV-2 pulmonary infection at the microanatomical, cellular, and molecular level.

5 July 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
EPEnrique Podaza
Enrique Podaza
JCJared Capuano
Jared Capuano
MAMajd Al Assaad
Majd Al Assaad
HKHui-Hsuan Kuo
Hui-Hsuan Kuo
GMGeoffrey Markowitz
Geoffrey Markowitz
MMMaria Laura Martin
Maria Laura Martin
Patient derived tumor organoids (PDTOs) have become relevant pre-clinical models for therapeutic modelling since they highly recapitulate patients’ response to treatment. Nevertheless, their value for immunotherapy modelling has not been fully explored. We developed a tumor processing protocol that enable the establishment of PDTOs and tumor infiltrating lymphocytes (TILs) isolation. By the optimization of functional assays, we compared the T-cells effector functions of matching PBMCs and TILs, demonstrating that PBMCs after co-culture and TILs after initial expansion display similar responses. In addition, the evaluation of cytokine production by fluorospot in combination with an image-based killing assay enable the screening of different immune-checkpoint inhibitors as well as its combination with target inhibitors. Our proof-of-concept functional assays showed the potential and versatility of PDTOs and T-cells co-culture systems for immunotherapy screening. The optimization of scalable functional assays downstream co-culture represents a significant step forward to increase the value of PDTOs as pre-clinical models for immunotherapeutic screens.